Prescription drug · NDA
Attruby (Acoramidis hydrochloride) NDC 82228-712
Acoramidis hydrochloride 356 mg/1 · Tablet, Film coated · Oral · BridgeBio Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82228-712-28 | 82228071228 | 4 DOSE PACK in 1 CARTON (82228-712-28) / 1 BLISTER PACK in 1 DOSE PACK / 28 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Nov 22, 2024 | |
| 82228-712-30 | 82228071230 | 1 BOTTLE in 1 CARTON (82228-712-30) / 120 TABLET, FILM COATED in 1 BOTTLEMarketed from Jun 18, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Attruby
- Generic name (nonproprietary)
- acoramidis hydrochloride
- Active ingredients
- Acoramidis hydrochloride — 356 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- BridgeBio Pharma, Inc.NDC labeler code 82228
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 216540
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inhibitors (Mechanism)Transthyretin Stabilizers (Mechanism)
- Identifiers
- Product ID 82228-712_c0fcfa4c-0b57-4260-839e-51171b7f1baaSPL ID c0fcfa4c-0b57-4260-839e-51171b7f1baaSPL set ID 913552ef-875d-4cb7-bf05-a7d20a394c38RxCUI 2698318, 2698324UNII VY9C88C2NVUPC 0382228712287, 0382228712300
- Pharmacologic class
- Transthyretin Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482228071228followed by a unit qualifier and the quantityPackage 82228-0712-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ATTRUBY is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ATTRUBY is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ( 1 , 2.1 )
Excerpt only. Read the full label for complete information.
About NDC 82228-712
- What is NDC 82228-712?
- 82228-712 is the product NDC for Attruby (acoramidis hydrochloride), Acoramidis hydrochloride 356 mg/1 tablet, film coated, listed with the FDA by BridgeBio Pharma, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Attruby (Acoramidis hydrochloride).
- What is the active ingredient?
- Acoramidis hydrochloride.
- Who is the labeler?
- BridgeBio Pharma, Inc., NDC labeler code 82228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Attruby?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.